These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 29283124)

  • 1. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.
    Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S
    Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
    Venkateswaran N; Mercado C; Galor A; Karp CL
    Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
    Kaliki S; Bejjanki KM; Desai A; Mohamed A
    Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
    Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
    Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
    Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of topical 0.5% 5-Fluorouracil as primary treatment of ocular surface squamous neoplasia.
    Kato JM; Ballalai PL; de Lima PP; Santo RM
    Can J Ophthalmol; 2024 Oct; 59(5):e510-e514. PubMed ID: 38631493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea.
    Yeatts RP; Ford JG; Stanton CA; Reed JW
    Ophthalmology; 1995 Sep; 102(9):1338-44. PubMed ID: 9097771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes.
    Agarwal A; Ghose N; Rathi V; Khanna R; Kaliki S
    BMC Ophthalmol; 2024 Sep; 24(1):389. PubMed ID: 39227791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
    Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
    Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Ocular Surface Squamous Neoplasia with Topical and Intralesional Interferon Alpha 2B in Mexicans.
    Nava-Castañeda Á; Hernández-Orgaz J; Garnica-Hayashi L; Ansart A; Matus G; Tovilla-Canales JL
    Nepal J Ophthalmol; 2018 Jul; 10(20):143-150. PubMed ID: 31056557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
    Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
    Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.
    Kaliki S; Singh S; Iram S; Tripuraneni D
    Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon Alfa-2b for Pigmented Ocular Surface Squamous Neoplasia: A Report of 8 Lesions.
    Kaliki S; Sharma A; Vempuluru VS
    Cornea; 2021 Feb; 40(2):142-146. PubMed ID: 32355112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.